|
시장보고서
상품코드
1625481
바이오 패브리케이션 시장 규모, 점유율, 동향, 산업 분석 보고서 : 기술, 재료 유형, 용도, 최종 사용자, 지역별 - 시장 예측(2025-2034년)Biofabrication Market Size, Share, Trends, Industry Analysis Report: By Technology, Material Type, Application, End User, and Region - Market Forecast, 2025-2034 |
||||||
Polaris Market Research의 최신 조사에 따르면 바이오 패브리케이션 시장 규모는 2034년까지 316억 9,000만 달러에 이를 것으로 예상됩니다. 이 설문조사 보고서는 현재 시장 역학을 자세히 파악하고 향후 시장 성장에 대한 분석을 제공합니다.
바이오 패브리케이션 시장은 제약회사와 연구기관이 의약품 개발 파이프라인을 추진하는 가운데, 세계적으로 파이프라인 의약품이 증가하고 있는 것이 주요 요인이 되어 성장하고 있습니다. 다양한 개발 단계에 있는 의약품이 증가하는 가운데 인간의 생체 반응을 시뮬레이션할 수 있는 고도로 정확한 시험 방법에 대한 수요가 확대되고 있습니다. 3D 프린터로 조직 모델을 만드는 바이오 패브리케이션 기술은 이러한 요구에 유망한 솔루션을 제공합니다. 이러한 기술은 인간의 장기와 기관을 충실히 재현한 복잡한 조직 구조의 개발을 가능하게 하고 신약의 효능과 안전성을 평가하기 위한 보다 신뢰성 있는 플랫폼을 제공합니다. 의약품 시험의 정확성을 높이고 동물 모델에 대한 의존도를 줄이고 제약 업계가 새로운 치료법 및 치료법에 대한 투자를 계속하면서 윤리적 및 규제적 우려에 대처할 수 있습니다. 바이오 패브리케이션 시장은 혁신적인 검사 솔루션에 대한 요구가 증가함에 따라 이익을 얻고 있습니다. 이러한 수요 증가는 의약품 개발 프로세스를 가속화하고 의약품 연구의 전반적인 효능을 높이는 데 있어 바이오 패브리케이션이 중요한 역할을 한다는 것을 뒷받침합니다.
민간 부문과 공공 부문에 의한 R&D(R&D) 투자 증가는 예측 기간 동안 바이오 패브리케이션 시장의 성장을 뒷받침할 것으로 예상됩니다. 재정 지원의 확대는 개량형 3D 바이오프린팅 시스템이나 신규 바이오 재료 등 바이오 패브리케이션 기술의 진보를 가능하게 하고 있습니다. 이러한 투자 유입은 기술 혁신을 촉진하고 새로운 애플리케이션 개발을 가속화하며 바이오 패브리케이션 기술의 능력을 향상시킵니다. 자금이 계속 증가함에 따라 연구 기관과 기업은 조직 공학 및 재생 의료에 대한보다 정교한 접근법을 탐구하고 시장 성장을 더욱 촉진할 수 있습니다. 투자 증가는 첨단 기술 개발을 지원하고 바이오 패브리케이션의 잠재적 응용을 확대하는 공동 연구 및 파트너십을 촉진하며 의료 및 제약 분야에서 이러한 기술의 전반적인 진보와 채택에 기여합니다.
의약품 검사는 바이오 패브리케이션 시장의 성장을 견인하는 주요 용도입니다. 고정밀 인체 조직을 3D 프린팅로 만들 수 있으므로 의약품의 효과적인 시험이 가능해져 동물 모델에 대한 의존도가 저하되어 의약품의 안전성 평가가 향상될 수 있습니다. 바이오 패브리케이션 기술은 인간의 생물학적 성질을 충실히 모방한 복잡한 조직 모델의 개발을 가능하게 하고, 연구자는 의약품의 효능과 독성을 평가하기 위한 신뢰할 수 있는 플랫폼을 손에 넣을 수 있습니다. 이 진보는 의약품 개발 프로세스를 크게 강화하고 바이오 패브리케이션 솔루션 수요 증가에 기여하고 있습니다.
바이오 패브리케이션 시장 보고서 하이라이트
기술별로는 3D 바이오프린팅 분야가 예측기간 동안 세계 시장에서 대폭적인 CAGR을 기록하여 큰 성장을 이룰 것으로 예측되고 있습니다. 이 성장은 정확성과 효율성을 높이는 기술의 발전으로 인한 것입니다.
의약품 검사 분야는 파이프라인 의약품 증가로 용도별로 2023년 시장에서 가장 큰 수익 점유율을 차지했습니다.
2023년 북미는 병원 수 증가, 대기업의 존재로 인해 세계 바이오 패브리케이션 시장을 독점했습니다.
인도의 바이오 패브리케이션 시장은 시험용 파이프라인 의약품 증가로 상당한 성장이 예상됩니다.
세계 주요 시장 기업으로는 Organovo Holdings, Inc., Cellink, Alevi, Aspect Biosystems, Prellis Biologics, Tissue Regenix, NanoScribe, Pandorum International Inc. 등이 있습니다.
목차
제1장 서론
제2장 주요 요약
제3장 조사 방법
제4장 세계의 바이오 패브리케이션 시장 인사이트
- 시장 현황
- 바이오 패브리케이션 시장 역학
- 성장 촉진요인과 기회
- 재생 의료 수요 증가
- 조직공학과 유전자 치료에 대한 투자 증가
- 성장 억제요인과 과제
- 바이오 패브리케이션 기술과 재료의 고비용
- 성장 촉진요인과 기회
- PESTEL 분석
- 바이오 패브리케이션 시장 동향
- 밸류체인 분석
- COVID-19의 영향 분석
제5장 세계의 바이오 패브리케이션 시장 : 기술별
- 주요 조사 결과
- 소개
- 3D 바이오프린팅
- 조직공학
- 바이오 재료의 제조
- 기타
제6장 세계의 바이오 패브리케이션 시장 : 재료 유형별
- 주요 조사 결과
- 소개
- 바이오잉크
- 생물세포
- 바이오 재료
- 기타
제7장 세계의 바이오 패브리케이션 시장 : 용도별
- 주요 조사 결과
- 소개
- 재생 의료
- 약물 검사
- 미용치료
제8장 세계의 바이오 패브리케이션 시장 : 최종 사용자별
- 주요 조사 결과
- 소개
- 학술연구기관
- 생명공학 및 제약회사
- 병원 및 전문 클리닉
제9장 세계의 바이오 패브리케이션 시장 : 지역별
- 주요 조사 결과
- 소개
- 바이오 패브리케이션 시장 평가 : 지역별(2020-2034년)
- 북미
- 북미 : 기술별(2020-2034년)
- 북미 : 재료 유형별(2020-2034년)
- 북미 : 용도별(2020-2034년)
- 북미 : 최종사용자별(2020-2034년)
- 미국
- 캐나다
- 유럽
- 유럽 : 기술별(2020-2034년)
- 유럽 : 재료 유형별(2020-2034년)
- 유럽 : 용도별(2020-2034년)
- 유럽 : 최종 사용자별(2020-2034년)
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
- 아시아태평양
- 아시아태평양 : 기술별(2020-2034년)
- 아시아태평양 : 재료 유형별(2020-2034년)
- 아시아태평양 : 용도별(2020-2034년)
- 아시아태평양 : 최종 사용자별(2020-2034년)
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
- 중동 및 아프리카
- 중동 및 아프리카 : 기술별(2020-2034년)
- 중동 및 아프리카 : 재료 유형별(2020-2034년)
- 중동 및 아프리카 : 용도별(2020-2034년)
- 중동 및 아프리카 : 최종사용자별(2020-2034년)
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 남아프리카
- 기타 중동 및 아프리카
- 라틴아메리카
- 라틴아메리카 : 기술별(2020-2034년)
- 라틴아메리카 : 재료 유형별(2020-2034년)
- 라틴아메리카 : 용도별(2020-2034년)
- 라틴아메리카 : 최종 사용자별(2020-2034년)
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카
제10장 경쟁 구도
- 확장 및 인수 분석
- 확장
- 인수
- 파트너십/협업/계약/공개
제11장 기업 프로파일
- Organovo Holdings, Inc.
- Cellink
- Allevi
- Aspect Biosystems
- Prellis Biologics
- Tissue Regenix
- NanoScribe
- Pandorum International Inc.
- AstraZeneca
- Dr. Reddy's Laboratory
- BASF Corporation
- Sun Pharmaceuticals Industries Ltd.
The biofabrication market size is expected to reach USD 31.69 billion by 2034, according to a new study by Polaris Market Research. The report "Biofabrication Market Size, Share, Trends, Industry Analysis Report: By Technology (3D Bioprinting and Tissue Engineering), Material Type, Application, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The biofabrication market is growing primarily due to an increase in pipeline drugs worldwide as pharmaceutical companies and research institutions advance their drug development pipelines. With a rising number of drugs in various stages of development, the demand for sophisticated and accurate testing methods that can simulate human biological responses is expanding. Biofabrication technologies, which involve creating 3D-printed tissue models, offer a promising solution for this need. These technologies enable the development of complex tissue structures that closely replicate human organs and systems, providing a more reliable platform for evaluating the efficacy and safety of new drugs. It improves the accuracy of drug testing and reduces reliance on animal models, addressing ethical and regulatory concerns as the pharmaceutical industry continues to invest in novel therapies and treatments. The biofabrication market benefits from the increased need for innovative testing solutions. This growing demand underscores the critical role of biofabrication in accelerating drug development processes and enhancing the overall effectiveness of pharmaceutical research.
An increase in investments in research and development (R&D) from the private and public sectors is expected to boost the biofabrication market growth during the forecast period. Growing financial support is enabling advancements in biofabrication technologies, such as improved 3D bioprinting systems and novel biomaterials. This influx of investment fosters innovation, accelerates the development of new applications, and enhances the capabilities of biofabrication technologies. As funding continues to rise, research institutions and companies can explore more refined approaches to tissue engineering and regenerative medicine, further driving market growth. Increased investments support the development of advanced technologies and facilitate collaborations and partnerships that expand the potential applications of biofabrication, contributing to the overall advancement and adoption of these technologies in the medical and pharmaceutical fields.
Drug testing is a major application driving the biofabrication market growth. The ability to create highly accurate, 3D-printed human tissues allows for effective testing of pharmaceuticals, potentially reducing reliance on animal models and improving drug safety assessments. Biofabrication technologies enable the development of complex tissue models that closely mimic human biology, offering researchers a more reliable platform for evaluating drug efficacy and toxicity. This advancement significantly enhances the drug development process, contributing to the growing demand for biofabrication solutions.
Biofabrication Market Report Highlights
Based on technology, the 3D bioprinting segment is anticipated to experience substantial growth with a significant CAGR in the global market during the forecast period. This growth is attributed to advances in technology that have enhanced precision and efficiency.
The drug testing segment, by application, accounted for the largest revenue share of the market in 2023 due to an increase in pipeline drugs.
In 2023, North America dominated the global biofabrication market due to the increasing number of hospitals, the presence of major players.
The biofabrication market in India is projected for substantial growth due to the increasing number of pipeline drugs for trials.
A few global key market players are Organovo Holdings, Inc.; Cellink; Allevi; Aspect Biosystems; Prellis Biologics; Tissue Regenix; NanoScribe; and Pandorum International Inc.
Polaris Market Research has segmented the biofabrication market report on the basis of technology, material type, application, end user, and region:
By Technology Outlook (Revenue - USD billion, 2020-2034)
- 3D Bioprinting
- Tissue Engineering
- Biomaterial Fabrication
- Other
- By Material Type (Revenue - USD billion, 2020-2034)
- Bioinks
- Biological Cells
- Biomaterials
- Others
- By Application (Revenue - USD billion, 2020-2034)
- Regenerative Medicine
- Durg Testing
- Cosmetic Treatment
- By End User (Revenue - USD billion, 2020-2034)
- Academic and Research Institutes
- Biotechnology and Pharmaceutical Companies
- Hospitals and Specialty Clinics
By Regional Outlook (Revenue - USD billion, 2020-2034)
- North America
- US
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Australia
- Rest of APAC
- Latin America
- Argentina
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
- Rest of MEA
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Biofabrication Market Insights
- 4.1. Biofabrication Market - Market Snapshot
- 4.2. Biofabrication Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increased in Demand for Regenerative Medicine is Driving the Market Size
- 4.2.1.2. Increase in Investment in Tissue Engineering and Gene Therapy Are Driving the Market Growth
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High Costs of Biofabrication Technology and Materials
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Biofabrication Market Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Biofabrication Market, by Technology
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Biofabrication Market, by Technology, 2020-2034 (USD Billion)
- 5.3. 3D Bioprinting
- 5.3.1. Global Biofabrication Market, by 3D Bioprinting, by Region, 2020-2034 (USD Billion)
- 5.4. Tissue Engineering
- 5.4.1. Global Biofabrication Market, by Tissue Engineering, by Region, 2020-2034 (USD Billion)
- 5.5. Biomaterial Fabrication
- 5.5.1. Global Biofabrication Market, by Biomaterial Fabrication, by Region, 2020-2034 (USD Billion)
- 5.6. Others
- 5.6.1. Global Biofabrication Market, by Others, by Region, 2020-2034 (USD Billion)
6. Global Biofabrication Market, by Material Type
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
- 6.3. Bioinks
- 6.3.1. Global Biofabrication Market, by Bioinks, by Region, 2020-2034 (USD Billion)
- 6.4. Biological Cells
- 6.4.1. Global Biofabrication Market, by Biological Cells, by Region, 2020-2034 (USD Billion)
- 6.5. Biomaterials
- 6.5.1. Global Biofabrication Market, by Biomaterials, by Region, 2020-2034 (USD Billion)
- 6.6. Others
- 6.6.1. Global Biofabrication Market, by Others, by Region, 2020-2034 (USD Billion)
7. Global Biofabrication Market, by Application
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Biofabrication Market, by Application, 2020-2034 (USD Billion)
- 7.3. Regenerative Medicine
- 7.3.1. Global Biofabrication Market, by Regenerative Medicine, by Region, 2020-2034 (USD Billion)
- 7.4. Drug Testing
- 7.4.1. Global Biofabrication Market, by Drug Testing, by Region, 2020-2034 (USD Billion)
- 7.5. Cosmetic Treatment
- 7.5.1. Global Biofabrication Market, by Cosmetic Treatment, by Region, 2020-2034 (USD Billion)
8. Global Biofabrication Market, by End User
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global Biofabrication Market, by End User, 2020-2034 (USD Billion)
- 8.3. Academic and Research Institutes
- 8.3.1. Global Biofabrication Market, by Academic and Research Institutes, by Region, 2020-2034 (USD Billion)
- 8.4. Biotechnology and Pharmaceutical Companies
- 8.4.1. Global Biofabrication Market, by Biotechnology and Pharmaceutical Companies, by Region, 2020-2034 (USD Billion)
- 8.5. Hospitals and Specialty Clinics
- 8.5.1. Global Biofabrication Market, by Hospitals and Specialty Clinics, by Region, 2020-2034 (USD Billion)
9. Global Biofabrication Market, by Geography
- 9.1. Key Findings
- 9.2. Introduction
- 9.2.1. Biofabrication Market Assessment, By Geography, 2020-2034 (USD Billion)
- 9.3. Biofabrication Market - North America
- 9.3.1. North America: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
- 9.3.2. North America: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
- 9.3.3. North America: Biofabrication Market, by Application, 2020-2034 (USD Billion)
- 9.3.4. North America: Biofabrication Market, by End User, 2020-2034 (USD Billion)
- 9.3.5. Biofabrication Market - U.S.
- 9.3.5.1. U.S.: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
- 9.3.5.2. U.S.: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
- 9.3.5.3. U.S.: Biofabrication Market, by Application, 2020-2034 (USD Billion)
- 9.3.5.4. U.S.: Biofabrication Market, by End User, 2020-2034 (USD Billion)
- 9.3.6. Biofabrication Market - Canada
- 9.3.6.1. Canada: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
- 9.3.6.2. Canada: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
- 9.3.6.3. Canada: Biofabrication Market, by Application, 2020-2034 (USD Billion)
- 9.3.6.4. Canada: Biofabrication Market, by End User, 2020-2034 (USD Billion)
- 9.4. Biofabrication Market - Europe
- 9.4.1. Europe: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
- 9.4.2. Europe: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
- 9.4.3. Europe: Biofabrication Market, by Application, 2020-2034 (USD Billion)
- 9.4.4. Europe: Biofabrication Market, by End User, 2020-2034 (USD Billion)
- 9.4.5. Biofabrication Market - UK
- 9.4.5.1. UK: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
- 9.4.5.2. UK: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
- 9.4.5.3. UK: Biofabrication Market, by Application, 2020-2034 (USD Billion)
- 9.4.5.4. UK: Biofabrication Market, by End User, 2020-2034 (USD Billion)
- 9.4.6. Biofabrication Market - France
- 9.4.6.1. France: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
- 9.4.6.2. France: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
- 9.4.6.3. France: Biofabrication Market, by Application, 2020-2034 (USD Billion)
- 9.4.6.4. France: Biofabrication Market, by End User, 2020-2034 (USD Billion)
- 9.4.7. Biofabrication Market - Germany
- 9.4.7.1. Germany: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
- 9.4.7.2. Germany: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
- 9.4.7.3. Germany: Biofabrication Market, by Application, 2020-2034 (USD Billion)
- 9.4.7.4. Germany: Biofabrication Market, by End User, 2020-2034 (USD Billion)
- 9.4.8. Biofabrication Market - Italy
- 9.4.8.1. Italy: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
- 9.4.8.2. Italy: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
- 9.4.8.3. Italy: Biofabrication Market, by Application, 2020-2034 (USD Billion)
- 9.4.8.4. Italy: Biofabrication Market, by End User, 2020-2034 (USD Billion)
- 9.4.9. Biofabrication Market - Spain
- 9.4.9.1. Spain: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
- 9.4.9.2. Spain: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
- 9.4.9.3. Spain: Biofabrication Market, by Application, 2020-2034 (USD Billion)
- 9.4.9.4. Spain: Biofabrication Market, by End User, 2020-2034 (USD Billion)
- 9.4.10. Biofabrication Market - Netherlands
- 9.4.10.1. Netherlands: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
- 9.4.10.2. Netherlands: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
- 9.4.10.3. Netherlands: Biofabrication Market, by Application, 2020-2034 (USD Billion)
- 9.4.10.4. Netherlands: Biofabrication Market, by End User, 2020-2034 (USD Billion)
- 9.4.11. Biofabrication Market - Russia
- 9.4.11.1. Russia: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
- 9.4.11.2. Russia: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
- 9.4.11.3. Russia: Biofabrication Market, by Application, 2020-2034 (USD Billion)
- 9.4.11.4. Russia: Biofabrication Market, by End User, 2020-2034 (USD Billion)
- 9.4.12. Biofabrication Market - Rest of Europe
- 9.4.12.1. Rest of Europe: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
- 9.4.12.2. Rest of Europe: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
- 9.4.12.3. Rest of Europe: Biofabrication Market, by Application, 2020-2034 (USD Billion)
- 9.4.12.4. Rest of Europe: Biofabrication Market, by End User, 2020-2034 (USD Billion)
- 9.5. Biofabrication Market - Asia Pacific
- 9.5.1. Asia Pacific: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
- 9.5.2. Asia Pacific: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
- 9.5.3. Asia Pacific: Biofabrication Market, by Application, 2020-2034 (USD Billion)
- 9.5.4. Asia Pacific: Biofabrication Market, by End User, 2020-2034 (USD Billion)
- 9.5.5. Biofabrication Market - China
- 9.5.5.1. China: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
- 9.5.5.2. China: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
- 9.5.5.3. China: Biofabrication Market, by Application, 2020-2034 (USD Billion)
- 9.5.5.4. China: Biofabrication Market, by End User, 2020-2034 (USD Billion)
- 9.5.6. Biofabrication Market - India
- 9.5.6.1. India: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
- 9.5.6.2. India: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
- 9.5.6.3. India: Biofabrication Market, by Application, 2020-2034 (USD Billion)
- 9.5.6.4. India: Biofabrication Market, by End User, 2020-2034 (USD Billion)
- 9.5.7. Biofabrication Market - Malaysia
- 9.5.7.1. Malaysia: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
- 9.5.7.2. Malaysia: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
- 9.5.7.3. Malaysia: Biofabrication Market, by Application, 2020-2034 (USD Billion)
- 9.5.7.4. Malaysia: Biofabrication Market, by End User, 2020-2034 (USD Billion)
- 9.5.8. Biofabrication Market - Japan
- 9.5.8.1. Japan: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
- 9.5.8.2. Japan: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
- 9.5.8.3. Japan: Biofabrication Market, by Application, 2020-2034 (USD Billion)
- 9.5.8.4. Japan: Biofabrication Market, by End User, 2020-2034 (USD Billion)
- 9.5.9. Biofabrication Market - Indonesia
- 9.5.9.1. Indonesia: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
- 9.5.9.2. Indonesia: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
- 9.5.9.3. Indonesia: Biofabrication Market, by Application, 2020-2034 (USD Billion)
- 9.5.9.4. Indonesia: Biofabrication Market, by End User, 2020-2034 (USD Billion)
- 9.5.10. Biofabrication Market - South Korea
- 9.5.10.1. South Korea: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
- 9.5.10.2. South Korea: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
- 9.5.10.3. South Korea: Biofabrication Market, by Application, 2020-2034 (USD Billion)
- 9.5.10.4. South Korea: Biofabrication Market, by End User, 2020-2034 (USD Billion)
- 9.5.11. Biofabrication Market - Australia
- 9.5.11.1. Australia: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
- 9.5.11.2. Australia: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
- 9.5.11.3. Australia: Biofabrication Market, by Application, 2020-2034 (USD Billion)
- 9.5.11.4. Australia: Biofabrication Market, by End User, 2020-2034 (USD Billion)
- 9.5.12. Biofabrication Market - Rest of Asia Pacific
- 9.5.12.1. Rest of Asia Pacific: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
- 9.5.12.2. Rest of Asia Pacific: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
- 9.5.12.3. Rest of Asia Pacific: Biofabrication Market, by Application, 2020-2034 (USD Billion)
- 9.5.12.4. Rest of Asia Pacific: Biofabrication Market, by End User, 2020-2034 (USD Billion)
- 9.6. Biofabrication Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
- 9.6.2. Middle East & Africa: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
- 9.6.3. Middle East & Africa: Biofabrication Market, by Application, 2020-2034 (USD Billion)
- 9.6.4. Middle East & Africa: Biofabrication Market, by End User, 2020-2034 (USD Billion)
- 9.6.5. Biofabrication Market - Saudi Arabia
- 9.6.5.1. Saudi Arabia: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
- 9.6.5.2. Saudi Arabia: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
- 9.6.5.3. Saudi Arabia: Biofabrication Market, by Application, 2020-2034 (USD Billion)
- 9.6.5.4. Saudi Arabia: Biofabrication Market, by End User, 2020-2034 (USD Billion)
- 9.6.6. Biofabrication Market - UAE
- 9.6.6.1. UAE: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
- 9.6.6.2. UAE: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
- 9.6.6.3. UAE: Biofabrication Market, by Application, 2020-2034 (USD Billion)
- 9.6.6.4. UAE: Biofabrication Market, by End User, 2020-2034 (USD Billion)
- 9.6.7. Biofabrication Market - Israel
- 9.6.7.1. Israel: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
- 9.6.7.2. Israel: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
- 9.6.7.3. Israel: Biofabrication Market, by Application, 2020-2034 (USD Billion)
- 9.6.7.4. Israel: Biofabrication Market, by End User, 2020-2034 (USD Billion)
- 9.6.8. Biofabrication Market - South Africa
- 9.6.8.1. South Africa: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
- 9.6.8.2. South Africa: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
- 9.6.8.3. South Africa: Biofabrication Market, by Application, 2020-2034 (USD Billion)
- 9.6.8.4. South Africa: Biofabrication Market, by End User, 2020-2034 (USD Billion)
- 9.6.9. Biofabrication Market - Rest of Middle East & Africa
- 9.6.9.1. Rest of Middle East & Africa: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
- 9.6.9.2. Rest of Middle East & Africa: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
- 9.6.9.3. Rest of Middle East & Africa: Biofabrication Market, by Application, 2020-2034 (USD Billion)
- 9.6.9.4. Rest of Middle East & Africa: Biofabrication Market, by End User, 2020-2034 (USD Billion)
- 9.7. Biofabrication Market - Latin America
- 9.7.1. Latin America: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
- 9.7.2. Latin America: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
- 9.7.3. Latin America: Biofabrication Market, by Application, 2020-2034 (USD Billion)
- 9.7.4. Latin America: Biofabrication Market, by End User, 2020-2034 (USD Billion)
- 9.7.5. Biofabrication Market - Mexico
- 9.7.5.1. Mexico: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
- 9.7.5.2. Mexico: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
- 9.7.5.3. Mexico: Biofabrication Market, by Application, 2020-2034 (USD Billion)
- 9.7.5.4. Mexico: Biofabrication Market, by End User, 2020-2034 (USD Billion)
- 9.7.6. Biofabrication Market - Brazil
- 9.7.6.1. Brazil: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
- 9.7.6.2. Brazil: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
- 9.7.6.3. Brazil: Biofabrication Market, by Application, 2020-2034 (USD Billion)
- 9.7.6.4. Brazil: Biofabrication Market, by End User, 2020-2034 (USD Billion)
- 9.7.7. Biofabrication Market - Argentina
- 9.7.7.1. Argentina: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
- 9.7.7.2. Argentina: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
- 9.7.7.3. Argentina: Biofabrication Market, by Application, 2020-2034 (USD Billion)
- 9.7.7.4. Argentina: Biofabrication Market, by End User, 2020-2034 (USD Billion)
- 9.7.8. Biofabrication Market - Rest of Latin America
- 9.7.8.1. Rest of Latin America: Biofabrication Market, by Technology, 2020-2034 (USD Billion)
- 9.7.8.2. Rest of Latin America: Biofabrication Market, by Material Type, 2020-2034 (USD Billion)
- 9.7.8.3. Rest of Latin America: Biofabrication Market, by Application, 2020-2034 (USD Billion)
- 9.7.8.4. Rest of Latin America: Biofabrication Market, by End User, 2020-2034 (USD Billion)
10. Competitive Landscape
- 10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
- 10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
- 11.1. Organovo Holdings, Inc.
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
- 11.2. Cellink
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
- 11.3. Allevi
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
- 11.4. Aspect Biosystems
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
- 11.5. Prellis Biologics
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
- 11.6. Tissue Regenix
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
- 11.7. NanoScribe
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
- 11.8. Pandorum International Inc.
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
- 11.9. AstraZeneca
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
- 11.10. Dr. Reddy's Laboratory
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
- 11.11. BASF Corporation
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
- 11.12. Sun Pharmaceuticals Industries Ltd.
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Benchmarking
- 11.12.4. Recent Development
(주말 및 공휴일 제외)
